Fischer Medical Ventures Ltd.
•Add ratio to table
ABOUT
AI Sector View
AI GENERATEDOil Gas & Consumable Fuels
Sector economics are clouded by input volatility and uneven volume trends. WPI fuel inflation is very high at 20.05% (Jul/26), crude oil output is -5.3% YoY (2026-07), natural gas is -3.7% YoY (2026-07), and natural gas consumption is -3.0% YoY (2026-06), although refinery products grew 2.7% YoY (2026-07) and coal was 7.6% YoY (2026-07). Heavy FPI outflows of INR -15293 crore over 3 months to 2026-08-31 and negative oil-linked news flow reinforce the underweight.
PROS
- Working capital cycle has improved - days down from 1158 to 869
- Company maintains a comfortable, low leverage position
CONS
- Operating cash flow has been negative in recent years
- A large part of profit comes from other income (67.1% of PBT)
- Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -31.27x)
- Promoter holding has decreased over last 2 years: -12.8pp
- Company has a low return on equity of 1.7% over last 3 years
- Company has a low return on capital employed of 3.8%
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
| Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| ADANIENT | 2894.80 | 52.64 | 391875.62 | 0.04 | -1461.54 | -249.67 | 32923.98 | 49.92 | 13.30 | 15.57 |
| PREMIERENE | 999.50 | 27.25 | 45372.45 | 0.10 | 471.92 | 53.32 | 2462.59 | 35.25 | 33.72 | 29.03 |
| CPPLUS | 3715.75 | 92.10 | 43957.48 | 0.04 | 142.20 | 332.51 | 1402.42 | 89.51 | 29.48 | 14.52 |
| AEGISLOG | 1242.80 | 34.86 | 43622.28 | 0.70 | 544.84 | 210.70 | 2356.86 | 37.07 | 19.76 | 30.28 |
| REDINGTON | 363.00 | 16.68 | 28378.41 | 1.65 | 453.49 | 94.65 | 34922.47 | 34.57 | 18.96 | 2.03 |
| HONASA | 470.45 | 61.63 | 15337.81 | 0.64 | 90.45 | 118.87 | 755.95 | 27.00 | 8.99 | 14.58 |
| LLOYDSENT | 70.95 | 96.45 | 10830.89 | 0.21 | 109.98 | -55.77 | 563.03 | 70.15 | 12.84 | 18.07 |
| SGMART | 825.65 | 83.70 | 10406.10 | 0.00 | 455.80 | 1310.71 | 13085.70 | 1044.08 | 10.43 | 4.49 |
| MMTC | 62.14 | 20.84 | 9321.00 | 0.00 | 104.24 | 135.52 | 0.68 | -50.00 | 33.46 | -1423.53 |
| ENTERO | 1799.70 | 62.46 | 7832.85 | 0.00 | 52.05 | 72.17 | 1940.50 | 38.23 | 10.93 | 5.00 |
| CELLO | 346.70 | 24.48 | 7658.08 | 0.43 | 73.40 | -8.99 | 526.72 | -0.43 | 17.15 | 18.80 |
| FISCHER | 37.88 | 88.74 | 2646.62 | 0.00 | 3.79 | -24.30 | 81.92 | 249.34 | 1.13 | 13.73 |
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | 10 | 40 | 12 | 49 | 23 | 86 | 101 | 98 | 82 | |
| 18 | 10 | 39 | 11 | 47 | 19 | 70 | 80 | 97 | 76 | |
| Operating Profit | 3 | -0 | 0 | 0 | 3 | 4 | 16 | 22 | 1 | 11 |
| OPM % | 12.07% | -2.47% | 1.26% | 4.26% | 5.10% | 17.19% | 18.83% | 21.34% | 1.03% | 13.73% |
| Other Income | 0 | 1 | 0 | 0 | 0 | 7 | 2 | 1 | 1 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 4 | 4 |
| Depreciation | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 3 | 0 | 0 | 0 | 2 | 10 | 17 | 21 | -2 | 8 | |
| Tax % | 6.18% | 237.50% | -21.05% | 168.00% | 26.04% | 50.84% | 19.48% | 9.18% | -216.00% | 51.60% |
| Net Profit | 0 | -0 | 0 | -3 | 1 | 5 | 14 | 19 | -7 | 4 |
| 1 | -0 | 0 | -0 | 0 | 0 | 2 | 0 | -0 | 0 | |
| Equity Capital | 54 | 54 | 54 | 54 | 64 | 65 | 65 | 65 | 65 | 65 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|
| 0 | 21 | 111 | 367 | |
| 0 | 19 | 107 | 322 | |
| Operating Profit | 0 | 2 | 5 | — |
| OPM % | 8 | 11 | 4 | — |
| Other Income | 0 | 1 | 1 | 6 |
| Interest | 0 | 0 | 0 | 9 |
| Depreciation | 0 | 0 | 2 | 4 |
| -0 | 2 | 2 | 44 | |
| Tax % | -2,708 | 13 | 46 | 32 |
| Net Profit | -0 | 2 | 1 | 30 |
| EPS | -2 | 0 | 0 | — |
| Dividend Payout % | 0 | 0 | 22 | — |
| Minority Interest | 0 | -0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | -0 |
| Adjusted EPS | -0 | 0 | 0 | — |
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- -66%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 2%
- Last Year:
- 1%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| LIABILITIES | - | - | - |
| Equity Capital | 0 | 54 | 64 |
| -0 | 27 | 244 | |
| 0 | 0 | 60 | |
| Trade Payables | 0 | 2 | 21 |
| 0 | 4 | 69 | |
| Total Liabilities | 0 | 86 | 457 |
| ASSETS | - | - | - |
| 0 | 15 | 24 | |
| Capital Work in Progress | 0 | 0 | 1 |
| 0 | 1 | 11 | |
| 0 | 4 | 9 | |
| 0 | 23 | 76 | |
| Cash & Bank | 0 | 38 | 251 |
| 0 | 5 | 85 | |
| Total Assets | 0 | 86 | 457 |
| Total Debt | 1 | 0 | 60 |
| Net Working Capital | 0 | 67 | 263 |
| Contingent Liabilities | 0 | 0 | 0 |
| Book Value per Share | -15.47 | 15.00 | 48.17 |
| Face Value | 10.00 | 10.00 | 10.00 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| 0 | -7 | -87 | |
| Cash from Investing | 0 | -31 | -125 |
| Cash from Financing | 0 | 37 | 315 |
| 0 | -2 | 103 | |
| Free Cash Flow | 0 | -23 | -99 |
| OCF / Net Profit | -0.00 | -4.00 | -71.81 |
| Cumulative 5-Year FCF | 0 | 0 | 0 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| PER SHARE | |||
| EPS (₹) | -2.12 | 0.26 | 0.23 |
| Book Value (₹) | -15.47 | 15.00 | 48.17 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.05 |
| Cash EPS (₹) | -0.21 | 0.04 | 0.04 |
| PROFITABILITY | |||
| Operating Margin % | 8.47% | 8.86% | 3.02% |
| Net Margin % | -20.33% | 8.76% | 1.09% |
| ROE % | 0.00% | 4.60% | 0.62% |
| ROCE % | 4.97% | 5.35% | 1.13% |
| -14.72% | 4.25% | 0.44% | |
| EFFICIENCY | |||
| Debtor Days | 347 | 200 | 163 |
| Inventory Days | 0 | 78 | 22 |
| Payable Days | 0 | 24 | 45 |
| 347 | 254 | 140 | |
| FINANCIAL HEALTH | |||
| Debt to Equity (x) | -2.15x | 0.00x | 0.20x |
| Interest Coverage (x) | 0.92x | 32.23x | 5.50x |
| 5.18x | 18.37x | 3.59x | |
| GROWTH | |||
| Revenue Growth % | 0.00% | 0.00% | 427.61% |
| Operating Profit Growth % | 0.00% | 0.00% | 104.82% |
| Net Profit Growth % | 0.00% | 5135.34% | -34.28% |
| 0.00% | 112.14% | -9.86% | |
| VALUATION | |||
| P/E (x) | 0.00x | 242.49x | 386.61x |
| P/B (x) | 0.00x | 41.65x | 18.64x |
| Dividend Yield % | 0.00% | 0.00% | 0.01% |
| 0.00x | 1399.44x | 1144.95x |
Documents
Corporate disclosures, annual reports, credit ratings, and concall transcripts
2026-09-03 - Fischer Medical Ventures Limited has informed the Exchange regarding Outcome of Board Meeting held on September 03, 2026.
2026-09-03 - Fischer Medical Ventures Limited has informed the Exchange about outcome of Board meeting held on 03/09/2026
2026-09-03 - Fischer Medical Ventures Limited has informed the Exchange that Record date for the purpose of Dividend is 22-Sep-2026.
2026-08-28 - Fischer Medical Ventures Limited has informed the Exchange regarding a press release dated August 28, 2026, titled "Time Medical International Ventures Launches Next-Generation CLARION 64/128-Slice AI-Driven CT System at India Health Expo 2026".
2026-08-24 - Fischer Medical Ventures Limited has informed the Exchange regarding a press release dated August 24, 2026, titled "Catanduanes Integrated Digital Healthcare Project Awarded to Time Medical Philippines Advancing the Digitalization of Universal Health Care in the Philippines".
2026-08-17 - Fischer Medical Ventures Limited has informed the Exchange on the allotment of Equity shares pursuant to conversion of warrants
2026-08-15 - Fischer Medical Ventures Limited has informed the Exchange about Resignation of Director/KMP/SMP
2026-08-15 - Fischer Medical Ventures Limited has informed the Exchange about Resignation of Director/KMP/SMP
2026-08-14 - Fischer Medical Ventures Limited has informed the Exchange on allotment of Equity shares pursuant to conversion of warrants
News
Recent coverage and analyst commentary for FISCHER
Loading news…
AI Stock Analyst
Fischer Medical Ventures Ltd.
Sign in to Chat with AI
Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.
✨ Sign In to ChatFree 5nance Account